/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Zoetis Inc. Share Price Today: Live Updates & Key Insights

Zoetis Inc. share price today is $115.72, up -3.61%. The stock opened at $118.87 against the previous close of $119.79, with an intraday high of $120.5 and low of $115.23.

Zoetis Inc. Share Price Chart

style
pb-0

Zoetis Inc.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Zoetis Inc. Share Price Performance

$115.72 -0.0361(-3.61%) ZTS at 13 Mar 2026 04:01 PM Drug Manufacturers - Specialty & Generic
Lowest Today 115.23
Highest Today 120.5
Today’s Open 118.87
Prev. Close 119.79
52 Week High 170.33
52 Week Low 114.76
Day’s Range: Low 115.23 High 120.5
52-Week Range: Low 114.76 High 170.33
1 day return -
1 Week return -4.93
1 month return -8.81
3 month return -4.57
6 month return -21.09
1 year return -27.84
3 year return -29.34
5 year return -25.46
10 year return -

Zoetis Inc. Institutional Holdings

Vanguard Group Inc 11.32

BlackRock Inc 8.58

J Stern & Co LLP 5.70

State Street Corp 4.65

Morgan Stanley - Brokerage Accounts 4.01

State Farm Mutual Automobile Ins Co 3.77

Vanguard Total Stock Mkt Idx Inv 2.96

Wellington Management Company LLP 2.70

Vanguard 500 Index Investor 2.66

Geode Capital Management, LLC 2.64

Polen Capital 1.78

Northern Trust Corp 1.42

Bank of America Corp 1.42

Wells Fargo & Co 1.40

NORGES BANK 1.38

iShares Core S&P 500 ETF 1.33

Fidelity 500 Index 1.33

State Street® SPDR® S&P 500® ETF 1.24

JPMorgan Chase & Co 1.24

Nordea Investment Mgmt Bank Demark A/s 1.17

Unisphere Establishment 1.14

Brown Advisory Holdings Inc 1.12

Deutsche Bank AG 1.11

The Goldman Sachs Group Inc 1.09

Mitsubishi UFJ Asset Management Co.,Ltd 1.02

Vanguard Mid Cap Index Institutional 1.02

Vanguard Dividend Growth Inv 0.96

Morgan Stanley Glbl Franchise 0.85

Fundsmith Equity I Acc 0.81

State Street®HlthCrSelSectSPDR®ETF 0.78

Vanguard Equity-Income Inv 0.77

MS INVF Global Brands A 0.75

Vanguard Growth Index Investor 0.63

Vanguard Institutional Index I 0.60

Vanguard Dividend Appreciation ETF 0.58

State St S&P 500® Indx SL Cl III 0.56

Diamond Hill Large Cap Equity 0.48

Vanguard Institutional 500 Index Trust 0.47

Fidelity Global Dividend I-Acc-EUR 0.46

Vanguard Value Index Inv 0.43

Zoetis Inc. Market Status

Strong Buy: 10

Buy: 4

Hold: 5

Sell: 0

Strong Sell: 0

Zoetis Inc. Fundamentals

Market Cap 52790.64 M

PB Ratio 15.2693

PE Ratio 19.9983

Enterprise Value 57494.68 M

Total Assets 15467.00 M

Volume 3955194

Zoetis Inc. Company Financials

Annual Revenue FY25:9467000000 9467.0M, FY24:9256000000 9256.0M, FY23:8544000000 8544.0M, FY22:8080000000 8080.0M, FY21:7776000000 7776.0M

Annual Profit FY25:6673000000 6673.0M, FY24:6537000000 6537.0M, FY23:5834000000 5834.0M, FY22:5626000000 5626.0M, FY21:5473000000 5473.0M

Annual Net worth FY25:2673000000 2673.0M, FY24:2486000000 2486.0M, FY23:2344000000 2344.0M, FY22:2114000000 2114.0M, FY21:2037000000 2037.0M

Quarterly Revenue Q4/2025:2387000000 2387.0M, Q3/2025:2400000000 2400.0M, Q2/2025:2460000000 2460.0M, Q1/2025:2220000000 2220.0M, Q4/2024:2317000000 2317.0M

Quarterly Profit Q4/2025:1644000000 1644.0M, Q3/2025:1685000000 1685.0M, Q2/2025:1778000000 1778.0M, Q1/2025:1566000000 1566.0M, Q4/2024:1610000000 1610.0M

Quarterly Net worth Q4/2025:603000000 603.0M, Q3/2025:721000000 721.0M, Q2/2025:718000000 718.0M, Q1/2025:631000000 631.0M, Q4/2024:581000000 581.0M

About Zoetis Inc. & investment objective

Company Information Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.

Organisation Drug Manufacturers - Specialty & Generic

Employees 14500

Industry Drug Manufacturers - Specialty & Generic

CEO Ms. Kristin C. Peck

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow